Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1121-1130 of 1,835) with videos related to

Pageof 184
Sort By:
Mabs|July 8, 2020
Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge regionMichael W Handlogten, Li Peng, Elizabeth A Christian, et al.
Mabs|March 31, 2023
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeuticsKyle P Martin, Christine Grimaldi, Rolf Grempler, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Mabs|April 19, 2021
Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1Weimin Chen, Madhu Pandey, Hong Sun, et al.
Mabs|April 20, 2021
Protective antibodies against human parainfluenza virus type 3 infectionJim Boonyaratanakornkit, Suruchi Singh, Connor Weidle, et al.
Mabs|April 20, 2021
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer modelsEmilia Rabia, Véronique Garambois, Julie Hubert, et al.
Mabs|April 12, 2021
Developments and opportunities in continuous biopharmaceutical manufacturingOhnmar Khanal, Abraham M Lenhoff
Mabs|February 6, 2025
Correction
Mabs|September 27, 2022
Investigating protein-excipient interactions of a multivalent V<sub>HH</sub> therapeutic protein using NMR spectroscopyJainik Panchal, Bradley T Falk, Valentyn Antochshuk, et al.
Mabs|November 28, 2023
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volumeM Desai, A Kundu, M Hageman, et al.
Pageof 184

Showing results (1121-1130 of 1,835) with videos related to

Sort By:
Pageof 184
Mabs|July 8, 2020
Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge regionMichael W Handlogten, Li Peng, Elizabeth A Christian, et al.
Mabs|March 31, 2023
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeuticsKyle P Martin, Christine Grimaldi, Rolf Grempler, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Mabs|April 19, 2021
Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1Weimin Chen, Madhu Pandey, Hong Sun, et al.
Mabs|April 20, 2021
Protective antibodies against human parainfluenza virus type 3 infectionJim Boonyaratanakornkit, Suruchi Singh, Connor Weidle, et al.
Mabs|April 20, 2021
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer modelsEmilia Rabia, Véronique Garambois, Julie Hubert, et al.
Mabs|April 12, 2021
Developments and opportunities in continuous biopharmaceutical manufacturingOhnmar Khanal, Abraham M Lenhoff
Mabs|February 6, 2025
Correction
Mabs|September 27, 2022
Investigating protein-excipient interactions of a multivalent V<sub>HH</sub> therapeutic protein using NMR spectroscopyJainik Panchal, Bradley T Falk, Valentyn Antochshuk, et al.
Mabs|November 28, 2023
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volumeM Desai, A Kundu, M Hageman, et al.
Pageof 184